Solid Pharmaceutical Compositions
Patent Information
- Application Number
- JP2024538350
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-12-30
- Filing Date
- 2022-12-28
- Publication Date
- 2024-11-29
- Estimated Expiration
- 2042-12-28
AI Technical Summary
The development of solid pharmaceutical compositions for the selective EP4 antagonist AN0025 faces challenges with high intra-batch variation in dissolution rates, leading to unreliable quality evaluation and difficulty in establishing consistent product quality control.
The formulation of AN0025 tablets using a combination of pharmaceutically acceptable carriers, including fillers, binders, disintegrants, and lubricants, through processes like dry or wet granulation, results in tablets with improved uniformity in in vitro dissolution and reduced individual variation in in vivo exposure.
The tablets exhibit lower dissolution variability, consistent in vivo exposure, and better bioavailability, ensuring improved process robustness and clinical efficacy.
Smart Images

Figure 2024544423000001_ABST
Abstract
Citation Information
Patent Citations
Highly disintegrable tablet
JP2002154948A
Solid preparation and method for producing the same
JP2005187464A
Pharmaceutical composition
JP2013538825A
Combination therapy for the treatment of cancer
JP2017516775A
Ramelteon-containing solid formulation
JP2020132613A
